NOVAVAX INC Debt Instrument, Face Amount
NOVAVAX INC (NVAX) had Debt Instrument, Face Amount of $325.00 million as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2022-11-09
- 2022-09-30: Debt Instrument, Face Amount $325.00M.
- 2022-06-30: Debt Instrument, Face Amount $325.00M.
- 2022-03-31: Debt Instrument, Face Amount $325.00M.
- 2021-12-31: Debt Instrument, Face Amount $325.00M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2022-09-30 | $325.00M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $325.00M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $325.00M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $325.00M 10-Q · filed 2022-11-09 |
| 2021-09-30 | $325.00M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $325.00M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $325.00M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $325.00M 10-K · filed 2022-03-01 |
| 2020-09-30 | $325.00M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $325.00M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $325.00M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $325.00M 10-K · filed 2021-03-01 |
| 2019-09-30 | $325.00M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $325.00M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $325.00M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $325.00M 10-K · filed 2020-03-11 |
| 2018-09-30 | $325.00M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $325.00M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $325.00M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $325.00M 10-K · filed 2019-03-18 |
| 2017-09-30 | $325.00M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $325.00M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $325.00M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $325.00M 10-Q · filed 2021-08-05 |
| 2016-09-30 | $325.00M 10-Q · filed 2021-05-10 |
| 2016-06-30 | $325.00M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $325.00M 10-Q · filed 2022-11-09 |
| 2015-12-31 | $0.00 10-K · filed 2017-02-27 |
| 2013-09-30 | $2.00M 10-Q · filed 2013-11-12 |
| 2012-09-30 | $2.00M 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |